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Abstract
Background: Falls among hospitalised patients impose a considerable burden on health systems globally and
prevention is a priority. Some patient-level interventions have been effective in reducing falls, but others have not.
An alternative and promising approach to reducing inpatient falls is through the modification of the hospital
physical environment and the night lighting of hospital wards is a leading candidate for investigation. In this pilot
trial, we will determine the feasibility of conducting a main trial to evaluate the effects of modified night lighting
on inpatient ward level fall rates. We will test also the feasibility of collecting novel forms of patient level data
through a concurrent observational sub-study.
Methods/design: A stepped wedge, cluster randomised controlled trial will be conducted in six inpatient wards
over 14 months in a metropolitan teaching hospital in Brisbane (Australia). The intervention will consist of
supplementary night lighting installed across all patient rooms within study wards. The planned placement of
luminaires, configurations and spectral characteristics are based on prior published research and pre-trial testing
and modification. We will collect data on rates of falls on study wards (falls per 1000 patient days), the proportion
of patients who fall once or more, and average length of stay. We will recruit two patients per ward per month to a
concurrent observational sub-study aimed at understanding potential impacts on a range of patient sleep and
mobility behaviour. The effect on the environment will be monitored with sensors to detect variation in light levels
and night-time room activity. We will also collect data on possible patient-level confounders including
demographics, pre-admission sleep quality, reported vision, hearing impairment and functional status.
Discussion: This pragmatic pilot trial will assess the feasibility of conducting a main trial to investigate the effects
of modified night lighting on inpatient fall rates using several new methods previously untested in the context of
environmental modifications and patient safety. Pilot data collected through both parts of the trial will be utilised
to inform sample size calculations, trial design and final data collection methods for a subsequent main trial.
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Background
Falls are among the most frequently reported adverse
events among hospital patients globally [1, 2], with re-
ported rates summarised as ranging from 1 to 9 falls per
1000 bed days [3]. Importantly, approximately 30 % of
all falls will result in some level of physical harm to pa-
tients [4]. While falls with serious injuries are less fre-
quent [5], these incidents are associated with substantial
health system costs [6, 7] and considerable elevation in
morbidity and mortality [8, 9]. Falls without injury are
also of concern as they can instil a fear of falling among
older people [10], which in turn may contribute to fu-
ture activity limitation and decline in function [11].
Overall, patients who fall in hospital are more likely to
experience longer hospital stays [12], poorer outcomes
at discharge [13] and require costly care [14]. Hence,
prevention of these incidents is an important priority for
health facilities.
A range of patient-related or intrinsic factors are
known to influence the risk of falls in hospital including
advanced age, illness status, functional limitations, cog-
nitive impairments and visual deficits [3, 15, 16]. In
addition to these, individual fall events may be also be
precipitated by extrinsic variables, such as the presence
of slip and trip hazards [5]. Intervention trials have
attempted to reduce falls by addressing various modifi-
able risk factors [4, 17–25], and some have demonstrated
effectiveness [4, 17–20]. Yet the inconclusive and nega-
tive results yielded by other studies [21–25] highlight
the challenges inherent in addressing the problem of
falls in the hospital setting. Hospital admissions are typ-
ically short; at-risk patients are often acutely ill and
present with multiple co-morbidities [26]. As a result,
the frequency and intensity of interventions necessary to
reverse many patient-level risk factors may be higher
than what is feasible in busy and challenging clinical en-
vironments. In this regard, targeting the environmental
contributors for falls [27–29], specifically through the
implementation of environmental redesign measures,
could offer some benefits over interventions delivered
directly to patients.
In comparison to patient-level intervention strategies,
measures involving environmental redesign would be as-
sociated with higher initial (fixed) costs but lower ongoing
(variable) costs. The initial outlay for environmental modi-
fications may be further lowered if incorporated in routine
refurbishments or in the construction of new facilities
[30]. More significantly, issues that hamper the delivery of
most patient-level interventions, such as fluctuating work-
loads and competing clinical priorities, would not dimin-
ish the effectiveness of environment redesign strategies.
Nevertheless, there has been scant research on environ-
mental redesign in the context of fall prevention in the
hospital setting and no experimental trials except for one
pilot study which evaluated the effects of an environmen-
tal redesign intervention (modified flooring) on injuries
from falls in hospital wards [31].
Environmental lighting and the risk of falls among
admitted patients
Environmental lighting at night has long been suspected
to exert an important influence on the risk of falls
among older hospital patients [32] and the prevalence of
visual impairment in people aged over 60 [33] is one of
the central issues. Age-related deterioration in the visual
system is most usually manifested as a loss of visual acu-
ity; however, problems such as reduction in the visual
field, lowered sensitivity to luminance contrast, and in-
creased sensitivity to glare are not uncommon [34]. Age-
ing is further associated with decreasing efficiency in the
visual system’s capacity to shift from photopic (normal
human vision in brightly lit conditions) to mesopic and
scotopic states (vision in transitional and dark condi-
tions, respectively) [35]. While loss of acuity is often cor-
rectable, narrowed visual field, degraded contrast
sensitivity, increased sensitivity to glare and slower
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adaptation responses to illumination changes are more
difficult to treat. These problems would present challenges
for older people as they may be more inclined to ambulate
at night [36, 37] and could explain the considerable num-
ber of night time inpatient falls that are reported [38].
Recognising the widespread nature of age-related de-
terioration in visual function, some authors have called
for better lighting to reduce falls in older populations
[39] and this would equally apply to the design of hos-
pital environments. However, bright lighting in patient
rooms at night is generally discouraged by applicable de-
sign standards [40]. Yet, patients who ambulate at night
may require higher light levels than what is normally
provided in sleep environments in order to safely ambu-
late [41]. In shared patient rooms where both sleep and
ambulatory activities may overlap, the disruptive effects
of excessive night lighting [42, 43] cannot be ignored.
Hence, a more considered approach is necessary when
designing night lighting profiles for older hospitalised
patients [44].
Proposed night lighting intervention to reduce falls
among admitted patients
A series of completed investigations have examined the
effects of various forms of indoor night lighting for older
people [45–47]. These studies found that at comparable
low illumination levels, indoor lighting systems that en-
hanced horizontal and vertical (H/V) spatial elements
were associated with the highest levels of performance
on standardised tests of gait and balance. H/V cues in
the above trials were generated through the use of light
emitting diode (LED) strips installed in linear arrays
around room design features of known dimensions and
orientation, specifically the bathroom doorframe. A
follow-up field study [48] assessed the suitability of a
similar LED-based night lighting scheme to address the
issue of insufficient lighting in residential care settings
[49] and to assist in fall prevention efforts. The tempor-
ary installations consisted of the LED-based H/V lighting
as per prior lab trials, but with the inclusion of add-
itional elements to meet the functional lighting needs of
older people within the room and bathroom environ-
ment [50]. These additional components were targeted
illumination (a) within the attached bathroom (in sec-
tions above the toilet and sink) and (b) under the resi-
dent’s bed to assist residents in finding footwear and to
identify hazards in the immediate vicinity of the bed. Il-
lumination levels in various locations within the room
were also objectively measured and reported on [51].
The study reported that residents and nursing staff
responded positively in post-trial interviews with ques-
tions spanning acceptability of the solution and partici-
pants’ subjective perception of lighting improvement.
Nursing staff also indicated that they would be less likely
to switch on overhead lights to conduct patient observa-
tions due to the presence of the night lighting. These
findings have been integrated into evidence-based rec-
ommendations for 24-h variable lighting systems in resi-
dential care settings with specific reference to the needs
of older people with dementia [52]. The LED luminaires
used in this series of research were reported as being of
‘amber’ colour and specifically selected to align with ex-
tensive literature on the photobiologic effects of light
[43, 53–55] and the perceptual-, health- and mood-
related benefits [56, 57] associated with the use of long
wavelength light. Notably, the measured illuminance
readings from the field trial [48, 51, 58] are within the
recommended ranges for patient room night lighting as
per Australian and New Zealand Interior lighting stan-
dards for hospitals [40].
We hypothesised that the introduction of a LED-based
night lighting scheme (the ‘intervention’) in hospital
rooms may contribute to fewer falls through several
mechanisms (Fig. 1), but primarily through safer overnight
ambulation among patients and reduced sleep disruption.
We also hypothesised that the intervention would reduce
peak lighting levels at night without impeding overnight
usage of toilets by patients and would enhance the per-
ceived environment from a patient perspective.
Objectives
The primary objective of this pragmatic pilot trial is to
understand the feasibility of the stepped wedged cluster
randomised controlled trial design to test the effects of
introducing modified night lighting across inpatient
wards to reduce fall rates. A secondary objective is to
study the feasibility of and value gained from a range of
proposed data collection methods aimed at understand-
ing the effects of the intervention at the patient level.
The pilot data will inform sample size calculations, assist
in the confirmation of intervention features, guide the
selection of data collection methods and finalise the
cost-effectiveness modelling approach to be adopted for
a subsequent main trail.
Methods/design
Setting
This pilot trial will be conducted in inpatient wards at
the Royal Brisbane and Women’s Hospital (RBWH). The
RBWH is a 929-bedded publically funded quaternary
and tertiary referral teaching hospital in a metropolitan
region in southeast Queensland, Australia and is part of
the Metro North Hospital and Health Service. A cen-
trally coordinated fall prevention program has been in
place at the RBWH for several years, and a consistent
approach to fall risk assessment and management is
followed across all inpatient wards.
Chari et al. Pilot and Feasibility Studies  (2016) 2:1 Page 3 of 14
Design
We will pilot a single-centre-stepped wedge cluster ran-
domised controlled trial (RCT) and a concurrent obser-
vational sub-study. The pilot RCT will be aimed at
evaluating the effects of the intervention on ward-level
fall rates and average length of ward admissions com-
pared to usual care. The mode, quality and quantity of
care delivered to patients in intervention wards will not
be altered by the pilot trial. The observational sub-study
will be conducted with a sample of patients admitted to
study wards and will help modelling effects of the inter-
vention on secondary patient- and room-level (environ-
mental) outcomes. The RBWH ethics review board
approved this study.
Design of stepped wedge cluster RCT
The pilot trial will be undertaken across six RBWH
wards (or clusters) and will be conducted over a 14-
month period. The pilot cluster RCT will be of a
‘stepped wedge’ design [59], which differs in some im-
portant respects from the design of a conventional clus-
ter RCT. A stepped wedge cluster RCT has clusters that
provide both control and intervention data. This is
achieved by implementing the intervention across all
clusters recruited to the study. However, the sequence in
which wards cross over from one condition to the other
is randomly determined. In this study, all of our study
wards will commence as controls at baseline. Figure 2
outlines the pattern in which study wards will transition
from control to intervention phases. The first ward to
transition to intervention phase will do so 2 months
after study commencement and subsequent wards will
transition to intervention phase at set intervals (or steps)
of 2 months until all wards have transitioned from
control to intervention phase. A further period of
2 months of data collection will be undertaken before
the study is complete. Thus, all wards will provide a
minimum of 2 months of control and intervention data.
The stepped wedge cluster RCT design described here is
increasingly seen as a suitable design for the pragmatic
evaluations of patient safety [60, 61] and service delivery
[62] interventions.
Wards and participants
We will recruit inpatient wards that are located at the
RBWH campus (excluding an off-campus rehabilitation
ward) with the highest reported rates of patient falls over
the preceding 2 years. No specific limits will be applied
to recruitment on the basis of service profile, patient
demographics or diagnostic grouping. However, plans
for ward closure or major physical refurbishments dur-
ing the study period will be criteria for non-inclusion
due to the potential for confounding effects on the pilot
trial. Once study wards have been identified, an inde-
pendent statistician will generate an implementation se-
quence using computer randomisation software. The
sequence of transition from control to intervention
phase will not be revealed en bloc and but rather one
ward at a time and 2 months prior to the date of transi-
tion. This would mean that the first ward to transition
Fig. 1 Postulated mechanisms of effect via which the night lighting intervention could reduce rates of falls on hospital wards
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from a control to an intervention phase will be revealed
to the study team at baseline (month ‘zero’), with the
transition to occur at the start of month ‘two’. Similarly,
the second ward to cross over will be revealed at the
start of month ‘two’ and cross over at the start of month
‘four’. This advance notification of wards due for transi-
tioning to the intervention phase is necessary to allow
adequate time for the hospital building and engineering
services to complete and test the installations across all
rooms in the ward (shared and single) in time for com-
mencement of the intervention phase. Analysis of fall
rates will be at the level of the ward and rely on data ag-
gregated from patient incident reports completed by
staff and from data coded routinely from the medical
record for all admitted patients. A waiver from seeking
individual patient-level consent for this component was
sought and granted by the RBWH institutional human
research and ethics committee.
Design of concurrent prospective observational sub-study
Detailed patient-level outcomes will be measured by sys-
tematic sampling across participating wards throughout
the pilot trial as part of a prospective observational sub-
study. One patient per ward per month will be recruited
from all six included wards (n = 84) and we will collect
data through a combination of self-report and continu-
ous monitoring, the details of which are described under
the ‘outcome measures’ section of this protocol. Written
consent will be secured prior to participant recruitment.
Patient eligibility will be established by the study re-
search officer (RO) in consultation with the ward nurse
manager or shift coordinator at each recruitment point.
The RO will be responsible for securing participant con-
sent. Some inclusion/exclusion criteria will apply to re-
cruitment. We will exclude patients who have been
admitted for longer than 30 days or are due to be dis-
charged within the following 3 days. Patients that have
been recruited to the current study in a previous month
will also be ineligible for recruitment. Patients with
known cognitive impairment will be excluded, as an im-
portant element of this sub-study is to capture data on
participant subjective experiences and this would be in-
feasible among cognitively impaired patients. Due to lack
of multi-language versions of the scales used in this
study, we will also exclude patients who are not fluent in
English. We will exclude patients who are unstable or
deemed too unwell to participate. Finally, patients aged
less than 65 years on the day of recruitment will also be
considered ineligible for recruitment.
Prior to the start of the study, the principal investiga-
tor (PI) will produce 84 sets of computer-generated
random integer sequences ranging from ‘1’ to the max-
imum number of bed locations in any ward, for example,
‘35’. These will then be printed and placed in sealed
opaque unmarked envelopes and handed over to a
RBWH Safety and Quality Unit (SQU) staff member
who is not involved with the study. At each recruitment
point, the RO will identify, in consultation with ward
nursing managers, patients who are eligible to be
approached for the study and a list of eligible bed num-
bers will be compiled and communicated to the nomi-
nated SQU staff member. The staff member will then
Fig. 2 Schematic diagram of study planned progression and trial design
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open one envelope and will generate the order of re-
cruitment as per the number sequence in the envelope.
This list will be provided to the RO for commencement
of recruitment. The PI will monitor recruitment to en-
sure adherence to the recruitment protocol. The RO will
approach the first bed number on the recruitment order;
if a patient does not consent to participate in the study,
this process will continue until a patient is successfully
recruited. This process will be replicated for each ward
at every recruitment point.
Sample size
For the cluster RCT, we are constrained by the available
funding as to the number of wards that can be included
in the pilot trial (six) and period for which data can be
collected (14 months), and hence, the overall anticipated
sample is estimated to be approximately 7500 patients.
While it is more usual for pilot studies to be conducted
with smaller sample sizes, physical design change of this
nature has never been undertaken within a stepped
wedge cluster RCT. Due to the potential of a variety of
operational and logistical challenges in installing new
equipment over entire wards, we anticipate that the
feasibility of such an approach will only be confirmed by
undertaking a rolling sequence of ward installations. In
this regard, installations in six wards would provide suf-
ficient opportunities to elicit the full range of practical
challenges that may be experienced and afford adequate
time to test and modify our implementation approach.
Hence, the larger sample size of the study can be consid-
ered a secondary feature of this pilot study rather than a
primary goal. Within these sample estimates, it is pos-
sible to directly calculate the likely effect size that we
can detect with 80 % power. Power for parallel cluster
randomised trial designs can be calculated by using a
conventional power analysis approach and then applying
a multiplier to compensate for a design effect, taking the
formula [1 + (n − 1)*p], where ‘n’ = the number of sub-
jects per cluster and ‘p’ = the intra-cluster correlation co-
efficient to take into account the dependency of
observations within clusters [63]. However, the stepped
wedge design additionally has a ‘within-cluster’ element
(that is, all clusters provide intervention and control
data), which provides power advantages to a parallel
cluster RCT in a similar way to the comparison of paired
with unpaired t tests. Hence, a power calculation specific
to stepped wedge designs is required. One previously de-
scribed approach highlights that stepped wedge designs
could reduce the required sample size in cluster ran-
domized trials [64], but is based upon the cohort style of
stepped wedge design where individual participants are
repeatedly measured across the length of the study. This
is not consistent with our planned study, which reflects
more a cross-sectional style of stepped wedge where
individual participants are likely to only have one meas-
urement for their involvement in the study. Fortunately,
another power analysis approach based on the cross-
sectional style of stepped wedge trial better suited for
examining a dichotomous outcome (that is, for compar-
ing patients who fall with those who do not) has been
developed [65]. Using this approach, our study has 83 %
power to detect an absolute reduction in the proportion
of patients who are fallers (patients who experience one
or more falls) from 5 % (in control) to 4 % (in interven-
tion) assuming 1071 patients per time period (total n ≈
7500), a coefficient of variation of 0.4, and using six clus-
ters (wards), seven time periods (six steps plus baseline)
and a two-tailed alpha of 0.05. This represents a 20 %
relative reduction in the proportion of patients who be-
come fallers. We anticipate that the minimum important
difference for our intervention is likely to be lower than
this since an effect size as low as 5 % relative reduction
could still represent a cost-effective solution. Nonethe-
less, in line with the pilot aims of this trial (primarily
focused on feasibility), statistical power and cost-
effectiveness are not primary considerations and will be
the focus of a subsequent main study if the main aims of
this pilot trial are satisfactorily met.
Intervention
The lighting system specifications and installation
scheme to be tested in the present pilot trial are aligned
with prior research, described in detail by Figueiro and
colleagues [46, 51, 58]. However, extensive in-hospital
modelling and testing was undertaken by the investiga-
tive team in preparation for the present pilot trial guided
by the United Kingdom Medical Research Council guid-
ance on the development and evaluation of complex in-
terventions [66]; certain design modifications were
found to be necessary. These modifications were (a) in-
corporation of aluminium channels and diffusers (top
plate) to house the LED luminaires in order to meet in-
hospital durability and disinfection requirements, (b)
elimination of the motion sensing feature described as
part of an earlier trial in residential care settings [48], so
as to avoid repeated and potentially disruptive cycles of
activation and deactivation in multi-occupancy patient
environments and (c) exclusion of under-bed lighting
due to the risk of loss of lighting units when hospital
beds are relocated, warranty concerns associated with
affixing electrical devices to hospital equipment, and the
possible confounding effects from the presence of inte-
grated under-bed lighting in certain newer bed models
procured at the RBWH. Proposed configurations and
placement of remaining lighting elements for the present
pilot trial will remain unchanged, although minor varia-
tions in installations are anticipated as electricians will
need to accommodate for differences in design features
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and to negotiate any unexpected engineering challenges
in individual rooms.
We will use commercially available LED strip lighting
with an output wavelength of 670 nm (orange colour),
which will be housed in aluminium tracks with diffuser
cover strips. The lights will be installed in the following
three locations across all patient rooms prior to each
ward’s transition to the intervention phase:
1. Around the exterior door frame of the attached
toilet: To provide a visual reference point for
patients attempting to mobilise to the toilet at night,
we will install a continuous length of strip lighting
around the exterior perimeter of the toilet door
frame.
2. Above the washbasin in attached toilets: In a
horizontal section below the mirror and above the
washbasin.
3. Behind the toilet/adjacent to the toilet: To facilitate
easy visualisation of the immediate area around the
toilet, we will install one section of lighting behind
to the toilet (above the cistern) and in a second
section over the grab rail (where a wall-mounted
grab rail is installed along the closest adjacent wall).
Due to known inter-ward variability in location of
toilets, type and location of grab rails within at-
tached bathrooms, it might not be feasible to install
grab rail lighting in all locations (such as when the
toilet is located equidistant from adjacent walls or if
bilateral fold-back grab rails are installed on the pos-
terior wall on either side of the toilet). In such in-
stances, we will make pragmatic decisions on
implementation feasibility and variation, which will
be comprehensively catalogued by the PI in a study
journal. Installation locations are also illustrated in
Fig. 3 and should be considered in conjunction with
images presented in prior studies [47, 48, 50–52, 58]
for approximations of spectral and illumination
characteristics.
RBWH electricians will install the LED lighting units
and installations will proceed in fully operational ward
environments, without bed closures or patient reloca-
tions. The PI will coordinate installations with ward
managers to ensure that minimal disruptions to normal
work flow occur while ensuring that electricians have
adequate access to the ward environment to install and
test the lighting and control systems. Output levels of in-
dividual luminaires have not been specified in the regis-
tered protocol as data of this nature was not available
prior to commencement. While it is planned that lumin-
aire output will closely follow output levels specified in
prior research [48, 51], further calibration will occur
during the installation process in consultation with clin-
ical staff and thereafter left unchanged for the duration
of the pilot trial. Resultant luminance (emitted light) will
be measured in situ after installations are complete and
reported on alongside pilot trial results to assist with
replication. Activation of the lighting units will be auto-
mated to ensure that they are operational overnight
(planned operation from 5 PM through to 7 AM). This
will help maximise service life and reduce power con-
sumption. The activation and deactivation times have
been selected to ensure availability of the lighting during
dark periods and so that local seasonal variations of sun-
rise and sunset times are accounted for. Importantly,
none of the existing lighting will be altered in any way,
and staff and patients will have full use of existing
Fig. 3 Illustration of in-room locations of lighting intervention and configuration of luminaire installation
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lighting in patient rooms and toilets if the installed night
lighting was considered inadequate or required supple-
mentation; for example, if additional light is required for
patients with severe visual impairment, or if a medical
emergency occurs.
Outcome measures
In this pilot cluster RCT, we will test the directionality
of intervention effects on ward level ‘rate of falls’ (num-
ber of falls per 1000 admitted patient days) and the pro-
portion of patients who have one or more falls as an
inpatient. Fall outcome data will be compiled from mul-
tiple sources, namely, (a) incident reports completed on
the Queensland Health (QH) clinical incident reporting
system, (b) periodic contact with the ward nurse unit
managers to identify any potentially unreported falls and
(c) data routinely extracted by clinical coders from pa-
tient medical records after discharge. The PI will extract
aggregated clinical incident reports on a monthly basis
to update the project database, adding any unreported
falls identified by the RO through ward contact. Add-
itional falls coded from medical records, length of stay,
ward bed occupancy and general demographic data for
patients in study wards will be extracted from the clin-
ical costing and case-mix system maintained by RBWH
Health Information Services (HIS). These coded data
will be extracted 3 months after the conclusion of the
trial. To explore the effect of the intervention specifically
on night-time falls, we will also include a secondary sub-
analysis of the ‘rate of falls at night’ (falls occurring be-
tween the hours of 7 PM and 6 AM) using the same
statistical approach described here. We note that the de-
cision to include this secondary analysis is a protocol
modification that occurred after trial registration but be-
fore data was ready for statistical analysis.
The observational sub-study will help us in under-
standing the manner in which the modified environment
might influence patient level outcomes. Outcome mea-
sures will primarily aim to capture data on sleep quality,
overnight activity levels, insomnia and daytime sleepi-
ness. Table 1 describes the tools that will be utilised to
collect this data.
A secondary focus will be participant self-reported
premorbid sleep quality, vision, hearing, functional sta-
tus, self-reported causes for disruption to sleep in
hospital, participant light dosage levels and overall satis-
faction with the room physical environment. Data on en-
vironmental lighting (within participant rooms) will be
captured continuously using environmental sensors and
data loggers. Secondary measures and environmental
monitoring modalities are described in Table 2. All mea-
sures will be collected at the initial interview. Wrist acti-
graph and environmental sensors will also be applied at
the time of the initial interview. Repeat measures (with
the exception of premorbid sleep, current vision and
hearing status) will be collected every 3 days (plus or
minus 1 day) up to day 12 or discharge/transfer, which-
ever occurs earlier. The collection of these data will pro-
vide a detailed context for understanding potential
mechanisms of effect for the intervention.
A final issue relates to the measurement of inter-
vention fidelity. While intervention delivery itself does
not require monitoring in this trial due to the auto-
mated nature of the intervention, it will be important
to understand whether patient and staff usage of
existing lighting is different before and after installa-
tion. Undertaking night-time visual observations was
not considered possible within the limited scope of
this pilot trial. We therefore sought to collect data on
lighting usage through the implementation of auto-
mated environmental monitoring solutions. ‘Illumin-
ance’ data (incident light on a given surface expressed
in ‘Lux’ or lumens per square metre) will be collected
in both pre-implementation and post-implementation
phases through the use of sensors (with data logging
capabilities) affixed in rooms and toilets of patients
recruited to the observational sub-study. Through
comparison of these data with visually validated refer-
ence data collected in the study wards, we will be
able to classify the majority of room lighting states
with a high degree of confidence (that is into ‘non-lit’,
‘LED lighting only’ and ‘operational ceiling lights’ cat-
egories). Further, we will be able to identify the tim-
ing, frequency and duration of intervals between state
changes. While it would be difficult to attribute state
changes to patients or staff based upon this data alo-
ne—comparison with patient time-stamped sleep and
activity data collected via wrist actigraphs will help us
exclude patient action in some instances where the
recruited patient was clearly not the agent causing
the state change (for example, if actigraphy data indi-
cates the patient was asleep).
Masking
Research staff responsible for collecting and entering
of data for the cluster RCT will not be blinded to the
identity of control or intervention wards, and the na-
ture of the intervention precludes blinding among
ward staff. For the observational sub-study, selection
order will be masked from research staff until a list
of eligible patients is compiled for each ward. Patients
recruited to the observational sub-study will only be
advised that the interview is part of study related to a
larger research trial examining links between the hos-
pital physical environment and patient outcomes.
However, it is possible that some patients on inter-
vention wards become aware of the intervention
during the course of their admission.
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Statistical analysis
The analysis of primary outcomes will be with multi-
level mixed effects generalised linear models using a
Bernoulli family and logit link for the ‘proportion of pa-
tients who become fallers’ outcome and a negative bino-
mial family and log link for the ‘rate of falls’ outcome. In
these analyses, patient admissions will be nested within
ward in the random effects part of the equation to take
account of clustering of data by ward. The fixed part of
the equation will examine group effects (intervention vs
control phases) and adjust for time period. We will also
adjust for seasonal effects on fall rates (that is, we will
enter a covariate based on how many falls there were on
each ward over the same time period over the previous
2 years). In relation to the observational sub-study, we
will employ a full range of descriptive statistics to model
the main features and distribution characteristics of the
final data set. We will explore differences in patient
sleep data and self-reported sleep and mobility behaviour
collected over control and intervention periods through
both qualitative and quantitative methods. Longitudinal
data collected through actigraphy and environmental
sensing will be subjected to exploratory analysis using
pattern recognition and data filtering algorithms to clas-
sify the raw outputs against specific activity and event
markers. Aggregated environmental sensing data will be
graphically modelled through the development of scatter
plots and histograms for visual identification of patterns
and differences between control and intervention data.
Categorical data on the causes of sleep disruptions col-
lected through the patient interview tool will additionally
be subjected to content [67] and thematic [68] analysis.
Concurrently, we will undertake multi-level mixed effect
generalised linear modelling with the quantitative data
from the observational sub-study, using a Gaussian fam-
ily and identity link for normally distributed continuous
data. The random effects would be subjected to nested
analysis; however, the fixed effect cannot adjust for sea-
sonal variation, as we will not have access to any prior
data of this nature.
Economic analysis
Upon completion of the pilot trial, we will attempt cost-
effectiveness analysis with available data through the use
of a decision-analytic model to estimate the costs and
health effects that patients would experience with and
without the intervention [69]. The expected change in
costs and change in effects prompted by this intervention
will be used to estimate incremental cost-effectiveness ra-
tio (ICER), which provides a summary measure of ‘value
Table 1 Primary outcome measures for observational sub-study







In order to collect objective data on participant sleep
quality, sleep fragmentation, total sleep and overall
activity levels, we will use wrist actigraphy. Actigraphs are
wearable sensors that allow logging of movement data
and have been extensive used in clinical research.
Actigraphy data has been validated against gold-standard
polysomnography methods and offers a reliable tool for
measuring sleep outside of a sleep laboratory
environment [71].
Days 0, 3, 7 and 12, consisting of one initial interview
and a maximum of three follow-up interviews, unless
patient is discharged or moved to another room prior
to day 12. Days 3, 7 and 12 data collection will occur
±1 day to accommodate for weekends and public
holidays.
We will be using a Philips Actiwatch 2, which is a small,
rugged, waterproof wrist worn data logger with long
battery life and will provide us with a measure of rest-
activity patterns and sleep. The Philips Actiwatch range
has been applied in over 30 clinical trials to date
including the study of sleep-wake patterns in older
acute patients [72, 73].
Upon recruitment, the research officer will apply the
Actiwatch on the participant’s non-dominant wrist and
re-check application and wearing behaviour at every






The KSS is a short 9-item self-report questionnaire that
is a measure of a situational sleepiness. The KSS is




Insomnia is an important manifestation of sleep
disturbance and thus an important construct to measure.
The ISI is a brief validated 7-item self-report measure of
the individual’s subjective perception of insomnia (sleep
onset, maintenance and early and unintended waking) as
well as amount of concern generated due to those
symptoms. The ISI has been utilised in prior studies on
insomnia prevalence in older admitted populations [77].
As above.
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Table 2 Pre-admission participant characteristics and secondary measures for observational sub-study
Construct Tool Description Frequency of data collection
Pre-admission sleep Epworth
Sleepiness Scale
To explore whether any reported insomnia or
sleep fragmentation is new or pre-existing, we
will administer the Epworth Sleepiness Scale
(ESS). The ESS is a widely used and valid 8-item
self-administered instrument for measuring for
excessive daytime sleepiness [78]. Excessive daytime
sleepiness is associated with a range of disorders
and has been associated with falls in certain
older groups [79].
Initial interview only (day 0)
Vision impairment Impact of Visual
Impairment Scale
As participant visual status would influence the
benefit derived from an environmental lighting
solution we will ask participants to self-rate the
functional impact of any visual impairment using
the Impact of Visual Impairment Scale (IVIS). The
IVIS is a widely cited and validated brief five-item
instrument [80], which measures impact of vision
impairment in terms of difficulties with simple
tasks. Individual IVIS items are suited to older
people in the inpatient setting and measure
constructs relevant to study aims.
As above.
Hearing impairment Hearing Handicap
Inventory for the
Elderly—Screening
The presence of hearing impairment is of
secondary interest to contextualise data on
causes of sleep disruption as patients with
hearing impairment may be less affected by
environmental noise than those patients with
unimpaired hearing. We will measure the
functional impact of hearing impairment among
study participants by using the Hearing Handicap
Inventory for the Elderly—Screening (HHIE-S). The
HHIE-S is a short ten-item measure of the social,
emotional and functional impacts of hearing
impairment rather than a definitive measure of
the degree of hearing impairment [81]. However, as
a self-report measure, it has demonstrated
excellent reliability and specificity in detecting the








Sleep disruptions can occur due to multiple
factors in addition to light levels. Therefore, we
will ask patients to what degree their sleep was
disrupted by specific causes (rated on a 7-point
Likert-type scale ranging from ‘Never’ to
‘Constantly’).
Initial interview (day 0) and repeated on
days 3, 7, and 12 Maximum of three
follow-up interviews, unless patient is
discharged or moved to another room
prior to day 12. Follow-up data collection
will occur ±1 day to accommodate for
weekends and public holidays.
The specific items are ‘Pain or Discomfort’,
‘Anxiety and Thoughts’, ‘Feeling unwell’, ‘People
talking in your room’, ‘Alarms and sounds from
medical devices’, ‘Sounds made by other patients’,
‘Bright lights being left on overnight’, ‘Bright
lights being switch on while you sleep’, ‘Staff
providing care to you’, ‘Staff providing care to
others’ and ‘Volume of someone else’s television’.
The current 11 items represent a refinement over
a previous version that was developed after a
review of the hospital sleep literature and
modified following with admitted patients in the
prior (unpublished) modelling research
conducted by Chari S et al. to inform the present
pilot RCT.
Functional status 5-item Barthel
Index
We will measure patient functional status using
the 5-item Barthel Index [83] to capture any
variations in functional status as this would
influence the interpretation of mobility data
collected through continuous direct monitoring.
The Barthel Index is a widely used, valid and
accepted tool for screening and assessing
As above.
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for money’. This allows for a comparison of the night
lighting against other health care interventions so long as
the measures of health effect are comparable and can as-
sist in the estimation of health interventions that offer the
best value for money. The completion of economic mod-
elling from the pilot data will underpin the decision to
progress to a main trial and also inform the final eco-
nomic modelling approach to be adopted.
Post-implementation staff surveys
In line with pilot aims of this trial, we seek to concur-
rently understand whether the characteristics of the
intervention and chosen implementation methods may
be improved from the perspectives of clinicians provid-
ing care to patients on intervention wards and of ward
managers. This will involve short face-to-face interviews
with a sample of ward staff after the pilot trial is
complete. The interviews will seek to establish the level
of disruptive impact experienced by the ward while
installations were undertaken, to gauge overall staff sat-
isfaction with the intervention (after a period of incorp-
oration into normal practice upon conclusion of the
pilot trial) and to finally identify ways in which the im-
plementation approach and intervention characteristics
may be improved. The scope and focus of post-
implementation interviews will be informed by the
specific issues and installation challenges noted by the
investigations to have arisen over the course of the pilot
trial. Accordingly, a separate submission to the respon-
sible institutional review board will be made prior to
commencement of post-trial interviews.
Trial safety and data management
Project investigators will monitor implementation and
outcomes for the duration of the pilot trial. The PI will
monitor adverse event rates in intervention wards on a
continuous basis. All fall-related adverse events resulting
in injury will further be analysed individually to evaluate
Table 2 Pre-admission participant characteristics and secondary measures for observational sub-study (Continued)
independence in activities of daily living (ADL)






To evaluate overall participant satisfaction with the
physical environment of the room and bathroom, we
will ask participants to rate their level of satisfaction on
a 5-point Likert-type scale ranging from ‘Very satisfied’
to ‘Very Dissatisfied’. We will ask participants to suggest
potential improvements to the physical environment
that could help patients to feel more confident to move
about safely in their room and bathroom, to sleep better







The inbuilt light sensor will enable measurement of
dosage of ambient white light over a 24-h period. We
will set the sampling rate to one measurement
every 30 s.
Continuous measurement(commenced at








As the modified lighting will be installed both inside
the patient room and attached toilet, we will monitor
variations in overnight lighting levels using a data
logger (Onsetcomp HOBO U12-012) mounted on the
wall in the patient room and toilet. The HOBO U12-012
data logger is a high-frequency, high-resolution device
capable of a measuring range between 1 and 3000
lumens/square foot. As the Actiwatch sensor will be the
primary measure of participant white light dosage, we
will affix the data logger outside the immediate patient
bedside environment (outside the area circumscribed by
patient privacy curtains) in order to measure overall
variation in room lighting profile. We will set the










In order to understand whether participants may have
been exposed to the modified lighting environment
within the toilet overnight, we will log the times of
door opening and closing. This will be done through an
unobtrusive door mounted data logger that measures
contact with a magnetic latch (Onsetcomp HOBO
UX90-001). Thus, all state change events (door opening
and closing) will be captured. The HOBO UX90-001 is a
high-capacity data logger appropriate to measuring
simple state changes and will allow us to contextualise
activity levels at night.
As above.
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whether the intervention was a contributory factor. All
such investigations will be escalated to the Data Safety
Management Committee (DSMC) and Human Research
Ethics Committee (HREC). The DSMC will be estab-
lished composed of one experienced clinician with ex-
perience in acute care who is not a member of the
project investigative team and is not invested in study
outcomes (external to the RBWH), an investigator from
the research team, an RBWH patient safety representa-
tive and a senior clinician representative from the
RBWH. This committee will review the interim results
of the pilot trial and review any serious adverse events
or unexpected outcomes related to the pilot trial.
Reporting of any adverse events or unexpected outcomes
will be forwarded to the HREC when received. The in-
vestigative team member on the committee will be the
nominee for ensuring all communications and escala-
tions to the HREC.
In order to avert any unforeseen increase in falls at-
tributable to the intervention, we will monitor for any
elevations in falls in study wards after transition to an
intervention phase. An elevation of 30 % or more over
the previously reported peak in the preceding 12 months
will be the threshold for further investigation for poten-
tial attribution to the intervention. Findings will be esca-
lated to the project governance group, the chair of the
HREC and DSMC nominee for a decision on study con-
tinuance or cessation. If a decision for cessation is made
for this reason, the lighting will be disabled centrally in
all wards followed by physical removal of installations
over time.
Data will be collected in an identifiable form and
retained as such until linkage of all pilot trial data is
completed, upon which the entire dataset will be de-
identified prior to analysis. Data storage will be managed
in line with Queensland Health data retention and dis-
posal policies and HREC recommendations.
Discussion
This study will be one of the first pilot investigations
into the feasibility of the stepped wedge cluster RCT de-
sign to study the effects of hospital environmental modi-
fication on inpatient fall rates. The pilot trial also
includes a number of novel environmental sensing mo-
dalities for data acquisition that are expected to generate
new insights into the lighting of hospital wards before
and after introduction of the night lighting intervention
and potential impacts on night-time patient mobility be-
haviour and lighting exposure. The completion of this
work would provide impetus to further trial-based re-
search aimed at generating high-level evidence to inform
future hospital facility design and refurbishment efforts.
Finally, the conduct of this pilot trial will help confirm
the methodological suitability of the stepped wedge
cluster RCT design in the testing of environmental
modification interventions and clarify scope for progres-
sion towards a main trial.
There are a number of limitations of this pilot study.
Primary outcomes in this RCT, that is rate of falls and
number of patients who become fallers, will be esti-
mated by reviewing incident reports, via periodic contact
with ward manager and through post-trial acquisition of
routinely coded data from medical records. However, we
recognise that incomplete identification of fall incidents
is likely [70]. As indicated previously, and to the best of
our knowledge, the stepped wedge cluster RCT design
has never been applied to the testing of environmental
modification in any setting. Due to the untested nature
of this approach, the feasibility of this model and pos-
sible challenges in undertaking rolling installations in
operational wards remains unknown. Therefore, the pri-
mary value of this pilot trial will not be in the results of
statistical testing undertaken with pilot data, but rather
in confirming whether this is a suitable approach to test
the effects of hospital environmental change and in gen-
erating sufficient pilot data to test the postulated mecha-
nisms of effect, to confirm the feasibility and utility of
proposed data collection methods and to finalise inter-
vention features in advance of a larger follow-up trial.
Trial status
Recruitment ongoing, anticipated completion in September
2015.
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